Your browser doesn't support javascript.
loading
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.
Benotmane, Ilies; Bruel, Timothée; Planas, Delphine; Fafi-Kremer, Samira; Schwartz, Olivier; Caillard, Sophie.
Afiliación
  • Benotmane I; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France. Electronic address: ilies.benotmane@chru-strasbourg.fr.
  • Bruel T; Institut Pasteur, Université de Paris, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 3569, Virus and Immunity Unit, Paris, France; Vaccine Research Institute, Basic Division, Créteil, France.
  • Planas D; Institut Pasteur, Université de Paris, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 3569, Virus and Immunity Unit, Paris, France; Vaccine Research Institute, Basic Division, Créteil, France.
  • Fafi-Kremer S; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
  • Schwartz O; Institut Pasteur, Université de Paris, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 3569, Virus and Immunity Unit, Paris, France; Vaccine Research Institute, Basic Division, Créteil, France.
  • Caillard S; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Kidney Int ; 101(5): 1073-1076, 2022 05.
Article en En | MEDLINE | ID: mdl-35231463
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article